Pfizer Inc posted third-quarter profit well above analysts’ estimates on higher sales of cancer drug Ibrance and new heart medicine Vyndaqel, encouraging the largest U.S. drugmaker to lift its earnings forecast for the year.
Source:: Reuters – Business News
